First the Activists, Now The Competition: Actelion Faces Continued Challenges
This article was originally published in The Pink Sheet Daily
Executive Summary
Actelion may have rebuffed activist shareholders Elliott Advisors, but it now faces growing competition in its core PAH franchise.